Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2024-09-02 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
福建天衡联合律师事务所关于大博医疗科技股份有限公司2024年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of a company's 2024 first extraordinary general meeting (临时股东大会). It details the legality and validity of the meeting's process and resolutions. The document does not contain financial statements or performance data, nor is it a report of financial results or management discussion. It is a formal legal opinion on the shareholder meeting and its voting outcomes. This type of document is best classified as Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results and confirms the legality of the shareholder meeting resolutions.
2024-09-02 Chinese
关于计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about the provision for asset impairment as of the half-year period ending June 30, 2024. It details the impairment losses on various asset categories such as accounts receivable, inventory, goodwill, and contract assets. The document includes explanations of the impairment recognition standards, methods, and the approval process by the board and audit committee. It is a regulatory disclosure about accounting estimates and adjustments rather than a full financial report. The document length is 3889 characters, which is relatively short and focused on a specific accounting matter. It does not contain comprehensive financial statements or a full interim report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a specific announcement about asset impairment provisions and does not fit the definitions of Annual Report, Interim Report, or Audit Report. It is not a report publication announcement since it contains substantive information rather than just a notice of report availability.
2024-08-28 Chinese
关于厦门证监局对公司采取行政监管措施的整改报告
Regulatory Filings Classification · 95% confidence The document is a detailed report from a company (大博医疗科技股份有限公司) addressing administrative regulatory measures imposed by the Xiamen Securities Regulatory Bureau. It outlines the company's corrective actions and compliance improvements following the regulatory decision. The content focuses on governance, compliance, and internal control issues rather than presenting financial statements or earnings data. It is not an announcement of a report publication but a substantive corrective report. This fits best under the category of Regulatory Filings (RNS), which covers compliance documents and regulatory updates that do not fit other specific categories.
2024-08-28 Chinese
2024年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "大博医疗科技股份有限公司2024年半年度报告全文" which translates to "Double Medical Technology Inc. 2024 Semi-Annual Report Full Text." It contains detailed financial data, management discussion and analysis, company business overview, financial indicators, and operational details for the first half of 2024. The document includes comprehensive financial statements and analysis, typical of an Interim / Quarterly Report. The length is substantial (15,000 characters), and it contains actual financial data and management commentary, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-28 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2024年半年度报告摘要' which translates to '2024 Semi-Annual Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also includes shareholder information and notes on audit opinions and dividend plans. The document length is 2836 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. The content matches the characteristics of an Interim / Quarterly Report (IR), which covers a period shorter than a full fiscal year and includes actual financial statements and analysis. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2024
2024-08-28 Chinese
半年报董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's third board meeting, twelfth session, held on August 27, 2024. It includes approval of the 2024 semi-annual report and its summary, a special report on the use of raised funds, asset impairment provisions, and a regulatory rectification report. The document states that the full semi-annual report and other detailed reports are published elsewhere (on the cninfo website and designated media). The document itself does not contain the full semi-annual report or detailed financial statements but announces the board's approval of these reports and refers readers to where the full reports can be found. The document length is short (1337 characters), and it serves as a meeting resolution announcement and a notice of report approvals rather than the report itself. Therefore, it fits best as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR) or Report Publication Announcement (RPA), since it contains substantive board resolutions and approvals rather than just a notice of publication.
2024-08-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.